SUVENNSESuven Life Sciences Limited· PharmaceuticalsMediumNeutral
Announced Wed, 13 May · 14:09 IST

Suven Life Sciences Limited has informed the Exchange regarding Grant of 133200 Options.

Management Changes View source PDF

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.3%1-day move
₹213.10
prior close
₹213.81
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.1-0.0-1.4-3.3-0.7+18.9+27.6+26.2+24.8+25.5+26.8+68.5
Up moveDown movePending
AI summary

Suven Life Sciences Limited has granted 133,200 stock options (Grant-III) to eligible employees under the SLSL ESOP 2020 scheme. The exercise price is ₹55 per option, with vesting spread over three tranches starting May 2027 (40%), May 2028 (30%), and May 2029 (30%). Each option entitles the holder to one equity share of face value ₹1. No options have been exercised or lapsed as of yet. The exercise period extends up to two years from the date of vesting.

Likely market impact

This is a routine ESOP grant that aligns employee interests with company performance. It has a modest dilutive impact of 133,200 shares (about 0.1% of total shares), which is immaterial for shareholders in the near term.